Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspiration with versus without intra-articular tranexamic acid and lidocaine for acute knee hemarthrosis in adults with hemophilia
IRCT20221216056838N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid and lidocaine in hemophilia (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Age, Gender and 6 more. Started Mar 2023; status: completed.
02
Drugs
tranexamic acidlidocaine
03
Conditions
hemophilia
Beyond the preview
Go deeper on IRCT20221216056838N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221216056838N1.